AKT1 and hepatocellular carcinoma: Another mechanistic study found that the inhibition of reactive oxygen species (ROS), the activation of the STAT3/Akt/Bcl-2 pathway, and the induced metastatic capacity of HCC cells were the leading causes of enhanced drug resistance in HCC (Wang et al., 2018).